PMGC (NASDAQ:ELAB – Get Free Report) and Transdigm Group (NYSE:TDG – Get Free Report) are both industrials companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, dividends, institutional ownership, analyst recommendations, profitability and earnings.
Earnings & Valuation
This table compares PMGC and Transdigm Group”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| PMGC | $590,000.00 | 2.15 | -$7.75 million | ($1,305.96) | -0.00 |
| Transdigm Group | $10.56 billion | 6.48 | $2.07 billion | $35.54 | 34.44 |
Transdigm Group has higher revenue and earnings than PMGC. PMGC is trading at a lower price-to-earnings ratio than Transdigm Group, indicating that it is currently the more affordable of the two stocks.
Institutional & Insider Ownership
22.2% of PMGC shares are held by institutional investors. Comparatively, 95.8% of Transdigm Group shares are held by institutional investors. 0.0% of PMGC shares are held by insiders. Comparatively, 3.2% of Transdigm Group shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Profitability
This table compares PMGC and Transdigm Group’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| PMGC | -522.92% | -118.83% | -60.03% |
| Transdigm Group | 19.94% | -24.14% | 11.18% |
Analyst Ratings
This is a summary of current ratings and recommmendations for PMGC and Transdigm Group, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| PMGC | 1 | 0 | 0 | 0 | 1.00 |
| Transdigm Group | 0 | 13 | 5 | 0 | 2.28 |
Transdigm Group has a consensus target price of $1,431.13, suggesting a potential upside of 16.93%. Given Transdigm Group’s stronger consensus rating and higher probable upside, analysts plainly believe Transdigm Group is more favorable than PMGC.
Risk & Volatility
PMGC has a beta of -0.27, suggesting that its share price is 127% less volatile than the S&P 500. Comparatively, Transdigm Group has a beta of 0.98, suggesting that its share price is 2% less volatile than the S&P 500.
Summary
Transdigm Group beats PMGC on 14 of the 14 factors compared between the two stocks.
About PMGC
Elevai Labs, Inc., a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs, Inc. was incorporated in 2020 and is based in Newport Beach, California.
About Transdigm Group
TransDigm Group Incorporated designs, produces and supplies highly engineered components for the aerospace industry. Its products include mechanical and electromechanical systems, pumps, valves, ignition systems, batteries, power-conditioning devices and cockpit components. The company serves commercial, military and business aviation markets, supplying components for both original aircraft production and the aftermarket. Its products are used on aircraft operated around the world, and its aftermarket business provides replacement parts and related support.
Receive News & Ratings for PMGC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PMGC and related companies with MarketBeat.com's FREE daily email newsletter.
